ginkgolide c has been researched along with Disease Models, Animal in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ahn, KS; Ha, IJ; Lee, SG; Um, JY; Yang, MH | 1 |
Cheng, J; Fu, S; Gao, S; Hu, G; Liu, D; Liu, J; Ma, H; Xu, D; Zhuang, L | 1 |
2 other study(ies) available for ginkgolide c and Disease Models, Animal
Article | Year |
---|---|
Abrogation of STAT3 activation cascade by Ginkgolide C mitigates tumourigenesis in lung cancer preclinical model.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinogenesis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Female; Ginkgo biloba; Ginkgolides; Humans; Lactones; Lung Neoplasms; Mice, Knockout; Phosphorylation; Phytotherapy; Plant Extracts; Plant Leaves; Receptor-Like Protein Tyrosine Phosphatases, Class 4; Signal Transduction; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2021 |
Orally Administered Ginkgolide C Attenuates DSS-Induced Colitis by Maintaining Gut Barrier Integrity, Inhibiting Inflammatory Responses, and Regulating Intestinal Flora.
Topics: Animals; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Gastrointestinal Microbiome; Humans; Lactones; Mice; Mice, Inbred C57BL; NF-kappa B; Tight Junction Proteins | 2022 |